Yan DongDong, Li WenQiang, Bai Ming, Wang Pei, Zhang Zheng
Department of Cardiology, First Hospital of Lanzhou University, Lanzhou, China.
First Clinical Medical College of Lanzhou University, Lanzhou, China.
Front Cardiovasc Med. 2025 Mar 28;12:1516054. doi: 10.3389/fcvm.2025.1516054. eCollection 2025.
ST-elevation myocardial infarction (STEMI) is a critical cardiovascular emergency characterized by acute coronary artery occlusion and subsequent myocardial injury. The current standard of care is primary percutaneous coronary intervention (PPCI), which aims to rapidly restore epicardial blood flow. However, despite successful revascularization, microvascular obstruction (MVO) remains a major challenge, contributing to adverse clinical outcomes. This article explores the potential role of intracoronary thrombolysis, in conjunction with thrombus aspiration, in improving microcirculatory perfusion during PCI for STEMI patients. The pathophysiology of MVO is systematically reviewed, followed by an evaluation of clinical studies on thrombus aspiration and intracoronary thrombolysis in STEMI management. Furthermore, the potential benefits of combining these two approaches in mitigating MVO are discussed. Finally, the clinical evidence is critically assessed, existing controversies are analyzed, and directions for future research are proposed.
ST段抬高型心肌梗死(STEMI)是一种危急的心血管急症,其特征为急性冠状动脉闭塞及随后的心肌损伤。当前的治疗标准是直接经皮冠状动脉介入治疗(PPCI),其目的是迅速恢复心外膜血流。然而,尽管血管再通成功,但微血管阻塞(MVO)仍然是一个重大挑战,会导致不良临床结局。本文探讨冠状动脉内溶栓联合血栓抽吸在改善STEMI患者PCI期间微循环灌注方面的潜在作用。系统回顾了MVO的病理生理学,随后评估了关于血栓抽吸和冠状动脉内溶栓在STEMI治疗中的临床研究。此外,还讨论了将这两种方法结合以减轻MVO的潜在益处。最后,对临床证据进行了严格评估,分析了存在的争议,并提出了未来研究的方向。